| Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer E Chirshev, KC Oberg, YJ Ioffe, JJ Unternaehrer Clinical and translational medicine 8 (1), 24, 2019 | 239 | 2019 |
| Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer N Hojo, AL Huisken, H Wang, E Chirshev, NS Kim, SM Nguyen, ... Scientific reports 8 (1), 8704, 2018 | 74 | 2018 |
| Epithelial/mesenchymal heterogeneity of high‐grade serous ovarian carcinoma samples correlates with miRNA let‐7 levels and predicts tumor growth and metastasis E Chirshev, N Hojo, A Bertucci, L Sanderman, A Nguyen, H Wang, ... Molecular oncology 14 (11), 2796-2813, 2020 | 28 | 2020 |
| The Epithelial–Mesenchymal Transcription Factor SNAI1 Represses Transcription of the Tumor Suppressor miRNA let-7 in Cancer H Wang, E Chirshev, N Hojo, T Suzuki, A Bertucci, M Pierce, C Perry, ... Cancers 13 (6), 1469, 2021 | 23 | 2021 |
| RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance CK Cajigas-Du Ross, SR Martinez, L Woods-Burnham, AM Durán, S Roy, ... Oncotarget 9 (54), 30363, 2018 | 23 | 2018 |
| Let-7i Reduces Aggressive Phenotype and Induces BRCAness in Ovarian Cancer Cells E Chirshev, T Suzuki, H Wang, A Nguyen, N Hojo, L Sanderman, ... Cancers 13 (18), 4617, 2021 | 14 | 2021 |
| TSLP as a potential therapy in the treatment of CRLF2 B cell acute lymphoblastic leukemia HR Alkashgari, C Ruiz-Jimenez, C Stoian, JS Coats, I Baez, E Chirshev, ... International journal of molecular sciences 24 (1), 474, 2022 | 4 | 2022 |
| Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer. Clin Transl Med. 2019; 8 (1): 24 E Chirshev, KC Oberg, YJ Ioffe, JJ Unternaehrer | 4 | |
| Mechanism of tumor suppressor miRNA let-7 downregulation in ovarian cancer: transcription factor Snail represses let-7 and is associated with invasiveness phenotype N Hojo, A Hill, E Chirshev, H Wang, Y Ioffe, J Unternaehrer Gynecologic Oncology 147 (1), 194, 2017 | 3 | 2017 |
| Let-7i Reduces Aggressive Phenotype and Induces BRCAness in Ovarian Cancer Cells. Cancers 2021, 13, 4617 E Chirshev, T Suzuki, H Wang, A Nguyen, N Hojo, L Sanderman, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Epithelial-mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with let-7 levels and predicts tumor growth and metastasis J Unternaehrer, E Chirshev, N Hojo, A Bertucci, L Sanderman, A Nguyen, ... Cancer Research 80 (16_Supplement), 1682-1682, 2020 | 1 | 2020 |
| Micro-Rna Let-7 Regulation and Function in Ovarian Cancer and Early Embryonic Development EA Chirshev, A Nguyen, H Nozomi, H Alyse, J Unternaehrer CLINICAL CANCER RESEARCH 25 (22), 152-152, 2019 | 1 | 2019 |
| Abstract A73: mechanism of tumor suppressor miRNA let-7 downregulation in ovarian cancer: the epithelial-mesenchymal transition factor Snail is associated with stemness and … A Huisken, N Hojo, H Wang, E Chirshev, C Glackin, Y Ioffe, ... Clinical Cancer Research 24 (15_Supplement), A73-A73, 2018 | 1 | 2018 |
| TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity Q Liu, S Chung, MM Murata, B Han, B Gao, M Zhang, TY Lee, E Chirshev, ... International Journal of Biological Sciences 18 (10), 4203, 2022 | | 2022 |
| Abstract TMIM-065: MICRO-RNA LET-7 REGULATION AND FUNCTION IN OVARIAN CANCER AND EARLY EMBRYONIC DEVELOPMENT EA Chirshev, A Nguyen, H Nozomi, H Alyse, J Unternaehrer Clinical Cancer Research 25 (22_Supplement), TMIM-065-TMIM-065, 2019 | | 2019 |
| Stem cell-like characteristics of patient-derived high-grade serous ovarian cancer xenografts are reversed by miRNA let-7 overexpression E Chirshev, N Hojo, L Sanderman, H Wang, LJ Hong, YJM Ioffe, ... Gynecologic Oncology 154, 178, 2019 | | 2019 |
| Mechanism of tumor suppressor miRNA let-7 downregulation in ovarian cancer: The epithelial-mesenchymal transition factor Snail is associated with stemness and represses let-7. A Huisken, N Hojo, H Wang, E Chirshev, C Glackin, Y Ioffe, ... CLINICAL CANCER RESEARCH 24 (15), 78-79, 2018 | | 2018 |
| Mechanism of tumor suppressor miRNA let-7 downregulation in ovarian cancer: The epithelial-mesenchymal transition factor Snail is associated with stemness and represses let-7 N Hojo, A Huisken, H Wang, E Chirshev, S Nguyen, C Glackin, Y Ioffe, ... Cancer Research 78 (13_Supplement), 1989-1989, 2018 | | 2018 |
| Biologic for the treatment of CRLF2 B-cell acute lymphoblastic leukemia to reduce pediatric cancer health disparities C Stoian, JS Coats, V Vidales, J Personius, E Chirshev, H Alkashgari, ... CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 27 (7), 145-146, 2018 | | 2018 |
| Abstract B71: Biologic for the treatment of CRLF2 B-cell acute lymphoblastic leukemia to reduce pediatric cancer health disparities C Stoian, JS Coats, V Vidales, J Personius, E Chirshev, H Alkashgari, ... Cancer Epidemiology, Biomarkers & Prevention 27 (7_Supplement), B71-B71, 2018 | | 2018 |
